Multiplexed protein detection using an affinity aptamer amplification assay

AbstractAffinity probe capillary electrophoresis (APCE) is potentially one of the most versatile technologies for protein diagnostics, offering an excellent balance between robustness, analysis speed and sensitivity. Combining the immunosensing and separating strength of capillary electrophoresis with the signal enhancement power of nucleic acid amplification, aptamers can further push the analytical limits of APCE to offer ultrasensitive, multiplexed detection of protein biomarkers, even when differences in electrophoretic mobility between the different aptamer–target complexes are limited. It is demonstrated how, through careful selection of experimental parameters, simultaneous detection of picomolar levels of three target proteins can be achieved even with aptamers that were initially selected under very different conditions and further taking into account that the aptamers need to be modified to allow successful PCR amplification. Aptamer-enhanced APCE offers limits of detection that are orders of magnitude lower than those that can be achieved through traditional capillary electrophoresis-based immunosensing. With recent developments in aptamer selection that for the first time realise the promise of aptamers as easily accessible, high affinity recognition molecules, it can therefore be envisioned that aptamer-enhanced APCE on parallel microfluidic platforms can be the basis for a truly high-throughput multiplexed proteomics platform, rivalling genetic screening for the first time. FigureMultiplexed affinity probe capillary electrophoresis (APCE) is enhanced through the use of PCR affinity aptamer amplification, improving both the limits of detection as well as the resolution of a typical APCE assay.

[1]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[2]  X Chris Le,et al.  Ultrasensitive detection of proteins by amplification of affinity aptamers. , 2006, Angewandte Chemie.

[3]  V. Prasad,et al.  HIV-1 reverse transcriptase mutations that confer decreased in vitro susceptibility to anti-RT DNA aptamer RT 1 t 49 confer cross resistance to other anti-RT aptamers but not to standard RT inhibitors , 2005 .

[4]  C. O’Sullivan Aptasensors – the future of biosensing? , 2002, Analytical and bioanalytical chemistry.

[5]  Hanlee P. Ji,et al.  Multiplexed protein detection by proximity ligation for cancer biomarker validation , 2007, Nature Methods.

[6]  M F Kubik,et al.  Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. , 1997, Journal of molecular biology.

[7]  T. Goldmann,et al.  Proteomics Out of the Archive: Two-dimensional Electrophoresis and Mass Spectrometry Using HOPE-fixed, Paraffin-embedded Tissues , 2010, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[8]  D. H. Burke,et al.  Broad-spectrum aptamer inhibitors of HIV reverse transcriptase closely mimic natural substrates , 2011, Nucleic acids research.

[9]  D. Drolet,et al.  An enzyme-linked oligonucleotide assay , 1996, Nature Biotechnology.

[10]  D. Whitcombe,et al.  The elimination of primer-dimer accumulation in PCR. , 1997, Nucleic acids research.

[11]  Michael Musheev,et al.  Non-SELEX selection of aptamers. , 2006, Journal of the American Chemical Society.

[12]  J. SantaLucia,et al.  A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Clive Brown,et al.  Toward clinical proteomics on a next-generation sequencing platform. , 2011, Analytical chemistry.

[14]  C. Broeckhoven The future of genetic research on neurodegeneration , 2010, Nature Medicine.

[15]  X Chris Le,et al.  Tunable aptamer capillary electrophoresis and its application to protein analysis. , 2008, Journal of the American Chemical Society.

[16]  Luigi Martino,et al.  Stability and binding properties of a modified thrombin binding aptamer. , 2008, Biophysical journal.

[17]  Dan Schneider,et al.  Expanding the chemistry of DNA for in vitro selection. , 2010, Journal of the American Chemical Society.

[18]  J. Feigon,et al.  Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Weihong Tan,et al.  Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells. , 2009, Analytical chemistry.

[20]  M. Levy,et al.  Kinetic optimization of a protein‐responsive aptamer beacon , 2009, Biotechnology and bioengineering.

[21]  Hugo Y. K. Lam,et al.  Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes , 2012, Cell.

[22]  J. Kinet,et al.  High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. , 1996, Journal of immunology.

[23]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[24]  Jeroen Lammertyn,et al.  Assay design considerations for use of affinity aptamer amplification in ultra-sensitive protein assays using capillary electrophoresis , 2011 .

[25]  Geoffrey S Baird,et al.  Where are all the aptamers? , 2010, American journal of clinical pathology.

[26]  Weihong Tan,et al.  Optimization and Modifications of Aptamers Selected from Live Cancer Cell Lines , 2007, Chembiochem : a European journal of chemical biology.

[27]  Xiluan Yan,et al.  DNA aptamer folding on magnetic beads for sequential detection of adenosine and cocaine by substrate-resolved chemiluminescence technology. , 2010, The Analyst.

[28]  Il-Hyun Kim,et al.  An alternative to Western blot analysis using RNA aptamer-functionalized quantum dots. , 2010, Bioorganic & medicinal chemistry letters.

[29]  L. Gold,et al.  High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. , 1995, Biochemistry.

[30]  Tracy R. Keeney,et al.  Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, Nature Precedings.

[31]  S. Kingsmore,et al.  Multiplexed protein profiling on microarrays by rolling-circle amplification , 2002, Nature Biotechnology.

[32]  Larry Gold,et al.  Proteomics and diagnostics: Let's Get Specific, again. , 2008, Current opinion in chemical biology.

[33]  Seung Soo Oh,et al.  Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing , 2010, Proceedings of the National Academy of Sciences.

[34]  S. P. Walton,et al.  Development of a dual-aptamer-based multiplex protein biosensor. , 2010, Biosensors & bioelectronics.

[35]  H. Schluesener,et al.  Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels , 2001, The Journal of Biological Chemistry.

[36]  D. Guyer,et al.  Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease , 2006, Nature Reviews Drug Discovery.

[37]  Jeffrey B.-H. Tok,et al.  Massively Parallel Interrogation of Aptamer Sequence, Structure and Function , 2008, PloS one.

[38]  Mark Gerstein,et al.  Personal phenotypes to go with personal genomes , 2009, Molecular systems biology.